[1]
Campos, R.A., Valle, S.O.R., França, A.T., Cordeiro, E., Serpa, F.S., Mello, Y.F., Malheiros, T., Toledo, E., Mansour, E., Fusaro, G. and Grumach, A.S. 2014. Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study. São Paulo Medical Journal. 132, 5 (Oct. 2014), 261–265.